IMR Press / EJGO / Volume 36 / Issue 4 / DOI: 10.12892/ejgo2686.2015

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Expression and significance of LRIG3 in human cervical squamous cell carcinoma
Show Less
1 Department of Gynaecology and Obstetrics, Central Hospital, Jiading District, Shanghai
2 Department of Pathology, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou
3 Departemnt of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou (China)
Eur. J. Gynaecol. Oncol. 2015, 36(4), 414–419;
Published: 10 August 2015

Objective: To explore the effect of LRIG3 in the development of cervical squamous cell carcinoma. Materials and Methods: LRIG3 and epidermal growth factor receptor (EFGR) expressions were detected by immunohistochemistry. Western blot method was used to detect LRIG3 and EGFR protein expression at different time points. MTT, flow cytometry, and transwell chamber were adopted to examine the proliferation, apoptosis, and strength of invasion of Hela229 cell respectively. Results: During the process of normal cervix deteriorating into CIN and CSCC, LRIG3 expression gradually decreased, while EGFR increased. After the transfection of LRIG3 ASODN into cells, the amount of LRIG3 expression and the cell apoptosis rate both decreased gradually, EGFR protein expression and cell proliferation rate both increased (p < 0.05), other groups remained unchanged (p > 0.05). The cell migration ability in LRIG3 ASODN transfection group was stronger than that of other groups (p < 0.05). Conclusion: LRIG3 plays an important role in Hela229 cell proliferation, apoptosis, and invasiveness.
Cervical squamous carcinoma
Immunohistochemical method
Back to top